Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis
暂无分享,去创建一个
P. Gregersen | J. Houwing-Duistermaat | T. Huizinga | R. Toes | Q. Helmer | S. Gay | R. Knevel | F. Kurreeman | P. Stinissen | M. Kern | A. H. M. van der Helm-van Mil | Nataly Manjarrez-Orduño | C. Ospelt | K. Klein | L. de Bock | V. Somers | G. Stoeken-Rijsbergen | D. De Rooy | J. V. van Nies | M. V. D. van der Linden | K. Somers | J. Schonkeren | Luis Rodriguez-Rodriquez
[1] A. Zhernakova,et al. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis , 2012, Annals of the rheumatic diseases.
[2] R. Tsonaka,et al. Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study , 2012, Annals of the rheumatic diseases.
[3] Posthumus,et al. Genetic variants in IL-15 associate with progression of joint destruction in rheumatoid arthritis, a multi cohort study , 2012 .
[4] K. Steinsson,et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study , 2012, Annals of the rheumatic diseases.
[5] Zhibing Zhang,et al. Spag16, an Axonemal Central Apparatus Gene, Encodes a Male Germ Cell Nuclear Speckle Protein that Regulates SPAG16 mRNA Expression , 2011, PloS one.
[6] T. Pap,et al. Therapeutic opportunities in fibroblasts in inflammatory arthritis. , 2010, Best practice & research. Clinical rheumatology.
[7] D. M. van der Heijde,et al. How to avoid phenotypic misclassification in using joint destruction as an outcome measure for rheumatoid arthritis? , 2010, Rheumatology.
[8] G. Firestein,et al. Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.
[9] R. Plenge,et al. Recent progress in rheumatoid arthritis genetics: one step towards improved patient care , 2009, Current opinion in rheumatology.
[10] P. Tak,et al. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. , 2008, Arthritis and rheumatism.
[11] P. Stinissen,et al. Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates1 , 2008, The Journal of Immunology.
[12] C. Hoggart,et al. Genome‐wide significance for dense SNP and resequencing data , 2008, Genetic epidemiology.
[13] S. Amselem,et al. A Heterozygous Mutation Disrupting the SPAG16 Gene Results in Biochemical Instability of Central Apparatus Components of the Human Sperm Axoneme1 , 2007, Biology of reproduction.
[14] Anbupalam Thalamuthu,et al. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. , 2007, The New England journal of medicine.
[15] T. Huizinga,et al. Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[16] P. Gregersen,et al. Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients. , 2006, Arthritis and rheumatism.
[17] F. Breedveld,et al. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[18] U. Müller-Ladner,et al. Are fibroblasts involved in joint destruction? , 2005, Annals of the rheumatic diseases.
[19] F. Breedveld,et al. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. , 2005, Arthritis and rheumatism.
[20] J. Ware,et al. Applied Longitudinal Analysis , 2004 .
[21] D. M. van der Heijde,et al. Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis , 2002, Annals of the rheumatic diseases.
[22] R. Toes,et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10 , 2002, Annals of the rheumatic diseases.
[23] James M Robins,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[24] A. Zwinderman,et al. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage. , 2002, Arthritis and rheumatism.
[25] S. Amselem,et al. Isolation and expression of the human hPF20 gene orthologous to Chlamydomonas PF20: evaluation as a candidate for axonemal defects of respiratory cilia and sperm flagella. , 2002, American journal of respiratory cell and molecular biology.
[26] P. Shekelle,et al. How to read radiographs according to the Sharp/van der Heijde method. , 1999 .
[27] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[28] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[29] T. Huizinga,et al. Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic? , 2011, Rheumatology.
[30] F. Wolfe,et al. The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. , 2011, Rheumatology.
[31] C. Potter,et al. Newcastle University E-prints Citation for Item: Baseline Serum Mmp-3 Levels in Patients with Rheumatoid Arthritis Are Still Independently Predictive of Radiographic Progression in a Longitudinal Observational Cohort at 8 Years Follow Up , 2022 .